{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:18:30Z","timestamp":1781194710420,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03040-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:08:11Z","timestamp":1751371691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A dynamic prediction model for predicting the time at which patients with MCI progress to AD based on time-dependent covariates"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pansheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3040_CR1","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"3040_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jalz.2017.11.004","volume":"14","author":"K Li","year":"2018","unstructured":"Li K, O\u2019Brien R, Lutz M, Luo S, The Alzheimer\u2019s Disease Neuroimaging Initiative. A prognostic model of Alzheimer\u2019s disease relying on multiple longitudinal measures and time-to-event data. Alzheimer\u2019s & Dementia. 2018;14:644\u201351.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"3040_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9:119\u201328.","journal-title":"Lancet Neurol"},{"key":"3040_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"3040_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1567205014666161213120807","volume":"14","author":"S Ellendt","year":"2017","unstructured":"Ellendt S, Vo\u03b2 B, Kohn N, Wagels L, Goerlich KS, Drexler E, et al. Predicting Stability of Mild Cognitive Impairment (MCI): findings of a Community Based Sample. Curr Alzheimer Res. 2017;14:608\u201319.","journal-title":"Curr Alzheimer Res"},{"key":"3040_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000354370","volume":"3","author":"A Ward","year":"2013","unstructured":"Ward A, Tardiff S, Dye C, Arrighi HM, Rate of conversion from prodromal Alzheimer\u2019s disease to Alzheimer\u2019s dementia: a systematic review of the literature. Dement Geriatr Cogn Dis Extra. 2013;3:320\u201332.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"3040_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-161201","volume":"58","author":"K Li","year":"2017","unstructured":"Li K, Chan W, Doody RS, Quinn J, Luo S, Alzheimer\u2019s Disease Neuroimaging Initiative. Prediction of Conversion to Alzheimer\u2019s Disease with Longitudinal Measures and Time-To-Event Data. J Alzheimers Dis. 2017;58:361\u201371.","journal-title":"J Alzheimers Dis"},{"key":"3040_CR8","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","volume":"32","author":"H Uno","year":"2014","unstructured":"Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014;32:2380\u201385.","journal-title":"J Clin Oncol"},{"key":"3040_CR9","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1200\/JCO.2015.64.2488","volume":"34","author":"L Trinquart","year":"2016","unstructured":"Trinquart L, Jacot J, Conner SC, Porcher R, Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials. J Clin Oncol. 2016;34:1813\u201319.","journal-title":"J Clin Oncol"},{"key":"3040_CR10","first-page":"260","volume":"19","author":"V Charu","year":"2023","unstructured":"Charu V, Tian L, Kurella Tamura M, Montez-Rath ME, Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis. Clin J Am Soc Nephrol. 2023;19:260\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3040_CR11","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.4274","volume":"30","author":"P Royston","year":"2011","unstructured":"Royston P, Parmar MKB, The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30:2409\u201321.","journal-title":"Stat Med"},{"key":"3040_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0962280209105020","volume":"19","author":"PK Andersen","year":"2010","unstructured":"Andersen PK, Perme MP, Pseudo-observations in survival analysis. Stat Methods Med Res. 2010;19:71\u201399.","journal-title":"Stat Methods Med Res"},{"key":"3040_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/biostatistics\/kxt050","volume":"15","author":"L Tian","year":"2014","unstructured":"Tian L, Zhao L, Wei LJ, Predicting the restricted mean event time with the subject\u2019s baseline covariates in survival analysis. Biostatistics. 2014;15:222\u201333.","journal-title":"Biostatistics"},{"key":"3040_CR14","doi-asserted-by":"publisher","first-page":"106155","DOI":"10.1016\/j.cmpb.2021.106155","volume":"207","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wu H, Hou Y, Yuan H, Chen Z, Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards. Comput Methods Programs Biomed. 2021;207:106155.","journal-title":"Comput Methods Programs Biomed"},{"key":"3040_CR15","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1111\/biom.13891","volume":"79","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zhang C, Hou Y, Chen Z, Analysis of dynamic restricted mean survival time based on pseudo-observations. Biometrics. 2023;79:3690\u2013700.","journal-title":"Biometrics"},{"key":"3040_CR16","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/CIRCULATIONAHA.122.060002","volume":"147","author":"LB Gordon","year":"2023","unstructured":"Gordon LB, Norris W, Hamren S, Goodson R, LeClair J, Massaro J, et al. Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: immunoassay Development and Clinical Evaluation. Circulation. 2023;147:1734\u201344.","journal-title":"Circulation"},{"key":"3040_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/biostatistics\/4.4.633","volume":"4","author":"PK Andersen","year":"2003","unstructured":"Andersen PK, Attenuation caused by infrequently updated covariates in survival analysis. Biostatistics. 2003;4:633\u201349.","journal-title":"Biostatistics"},{"key":"3040_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12561-016-9157-9","volume":"9","author":"H Putter","year":"2017","unstructured":"Putter H, Van Houwelingen HC, Understanding Landmarking and Its Relation with Time-Dependent Cox Regression. Stat Biosci. 2017;9:489\u2013503.","journal-title":"Stat Biosci"},{"key":"3040_CR19","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/aje\/kwy018","volume":"187","author":"E Paige","year":"2018","unstructured":"Paige E, Barrett J, Stevens D, Keogh RH, Sweeting MJ, Nazareth I, et al. Landmark Models for Optimizing the Use of Repeated Measurements of Risk Factors in Electronic Health Records to Predict Future Disease Risk. Am J Epidemiol. 2018;187:1530\u201338.","journal-title":"Am J Epidemiol"},{"key":"3040_CR20","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/sim.9336","volume":"41","author":"H Putter","year":"2022","unstructured":"Putter H, Van Houwelingen HC, Landmarking 2.0: bridging the gap between joint models and landmarking. Statistics in Medicine. 2022;41:1901\u201317.","journal-title":"Statistics in Medicine"},{"key":"3040_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E, Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303\u201308.","journal-title":"Arch Neurol"},{"key":"3040_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"3040_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/biomet\/asm036","volume":"94","author":"L Tian","year":"2007","unstructured":"Tian L, Cai T, Goetghebeur E, Wei LJ, Model evaluation based on the sampling distribution of estimated absolute prediction error. Biometrika. 2007;94:297\u2013311.","journal-title":"Biometrika"},{"key":"3040_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jalz.2010.04.005","volume":"7","author":"GA Marshall","year":"2011","unstructured":"Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA, et al. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:300\u201308.","journal-title":"Alzheimers Dement"},{"key":"3040_CR25","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/NDT.S263702","volume":"16","author":"YM Choe","year":"2020","unstructured":"Choe YM, Lee BC, Choi\u2013, Suh\u2013, Lee DY, Kim JW, et al. MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment. Neuropsychiatr Dis Treat. 2020;16:1767\u201375.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3040_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"3040_CR27","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1038\/s41467-021-26703-z","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Nasrallah IM, Shou H, Wen J, Doshi J, Habes M, et al. A deep learning framework identifies dimensional representations of Alzheimer\u2019s Disease from brain structure. Nat Commun. 2021;12:7065.","journal-title":"Nat Commun"},{"key":"3040_CR28","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03040-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:08:12Z","timestamp":1751371692000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3040"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03040-5","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The data in this study is available from the ADNI database. No new clinical data was gathered or used. There is thus no need for the ethical approval and consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Relevant guidelines and regulations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"226"}}